Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Modulation of human IGF binding protein-3 activity by structural modification

R C Baxter1, S M Firth

  • 1Kolling Institute of Medical Research, Royal North Shore Hospital, Sydney, NSW, Australia.

Progress in Growth Factor Research
|January 1, 1995
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The metabolism and toxicology of strontium-90 in the rat. Rationale, experimental procedures, pilot experiments.

UR [reports]. U.S. Atomic Energy Commission·2014
Same author

The effect of x-irradiation and of morbidity on strontium-90 absorption and retention by rats.

UR [reports]. U.S. Atomic Energy Commission·2014
Same author

Tissue biomarkers of breast cancer and their association with conventional pathologic features.

British journal of cancer·2013
Same author

The role of insulin-like growth factor binding protein-3 in the breast cancer cell response to DNA-damaging agents.

Oncogene·2012
Same author

Serum apolipoprotein C-II is prognostic for survival after pancreatic resection for adenocarcinoma.

British journal of cancer·2012
Same author

IGFBP-3 binds GRP78, stimulates autophagy and promotes the survival of breast cancer cells exposed to adverse microenvironments.

Oncogene·2012

The carboxy-terminal domain of Insulin-like Growth Factor Binding Protein 3 (IGFBP-3) is essential for cell surface binding, while the central domain is not required for this interaction. The basic region within the carboxy-terminal domain is crucial for cell association and influences IGF-I binding and ALS affinity.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Cell Biology

Background:

  • Insulin-like Growth Factor Binding Protein 3 (IGFBP-3) plays a critical role in regulating IGF bioavailability.
  • Understanding the specific domains of IGFBP-3 responsible for ligand and cell-surface interactions is crucial for deciphering its biological functions.

Purpose of the Study:

  • To delineate the specific regions of IGFBP-3 involved in binding to IGF-I and cell surfaces.
  • To investigate the role of different domains, including the central and carboxy-terminal regions, in IGFBP-3's cellular interactions.

Main Methods:

  • Transfection of Chinese Hamster Ovary (CHO) cells with DNA encoding human IGFBP-3 and its deletion variants.
  • Ligand blotting and immunoblotting to assess IGF-I and IGFBP-3 binding, respectively.

Related Experiment Videos

  • Cell-association assays and Scatchard analysis to evaluate binding affinities and cell surface interactions.

    • Main Results:

    • Deletion mutants in the central domain of IGFBP-3 did not bind IGF-I but retained detectability via immunoblotting.
    • The carboxy-terminal domain, specifically the basic region [228-232], was found to be essential for cell-surface association.
    • Mutation of the basic region reduced IGF-I binding and altered IGF-ALS binding affinity, implicating it in multiple interactions.

    Conclusions:

    • The ability of IGFBP-3 to associate with cell surfaces is primarily dependent on its carboxy-terminal domain, particularly the basic region.
    • While the central domain is not required for cell association, the carboxy-terminal basic region influences IGF-I binding and IGF-ALS affinity.
    • These findings highlight the distinct roles of IGFBP-3 domains in mediating interactions with ligands and the cell surface.